Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.
Identifieur interne : 004133 ( Ncbi/Merge ); précédent : 004132; suivant : 004134Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.
Auteurs : Win Lei Aye [Thaïlande] ; Apa Puckpinyo [Thaïlande] ; Karl Peltzer [Afrique du Sud]Source :
- BMC public health [ 1471-2458 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Agents antiVIH.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Agents antiVIH.
- Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Myanmar, Mâle, Observance du traitement médicamenteux, Prévalence, Études transversales.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Anti-HIV Agents.
- chemical , therapeutic use : Anti-HIV Agents.
- drug therapy : HIV Infections.
- statistics & numerical data : Medication Adherence.
- Adult, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Myanmar, Prevalence, Risk Factors.
Abstract
The provision of Anti-Retroviral Therapy (ART) was started in Myanmar in 2005 in collaboration with the National AIDS Program and the private sector. Successful clinical management of HIV-infected patients is subject to optimal adherence. The aim of the study was to determine the prevalence of adherence to ART and identify factors associated with non-adherence to ART among HIV infected adults registered in a private sector setting in Mon State, Myanmar.
DOI: 10.1186/s12889-017-4309-5
PubMed: 28476150
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000C21
- to stream PubMed, to step Curation: 000C21
- to stream PubMed, to step Checkpoint: 000C21
Links to Exploration step
pubmed:28476150Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.</title><author><name sortKey="Aye, Win Lei" sort="Aye, Win Lei" uniqKey="Aye W" first="Win Lei" last="Aye">Win Lei Aye</name><affiliation wicri:level="1"><nlm:affiliation>Master of Primary Health Care Management Program, ASEAN Institute for Health Development, Mahidol University, Nakhonpathom, Thailand. wlaye@iom.int.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Master of Primary Health Care Management Program, ASEAN Institute for Health Development, Mahidol University, Nakhonpathom</wicri:regionArea><wicri:noRegion>Nakhonpathom</wicri:noRegion></affiliation></author><author><name sortKey="Puckpinyo, Apa" sort="Puckpinyo, Apa" uniqKey="Puckpinyo A" first="Apa" last="Puckpinyo">Apa Puckpinyo</name><affiliation wicri:level="1"><nlm:affiliation>ASEAN Institute for Health Development, Mahidol University, Nakhonpathom, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>ASEAN Institute for Health Development, Mahidol University, Nakhonpathom</wicri:regionArea><wicri:noRegion>Nakhonpathom</wicri:noRegion></affiliation></author><author><name sortKey="Peltzer, Karl" sort="Peltzer, Karl" uniqKey="Peltzer K" first="Karl" last="Peltzer">Karl Peltzer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Research and Innovation, University of Limpopo, Sovenga, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Department of Research and Innovation, University of Limpopo, Sovenga</wicri:regionArea><wicri:noRegion>Sovenga</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28476150</idno><idno type="pmid">28476150</idno><idno type="doi">10.1186/s12889-017-4309-5</idno><idno type="wicri:Area/PubMed/Corpus">000C21</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C21</idno><idno type="wicri:Area/PubMed/Curation">000C21</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C21</idno><idno type="wicri:Area/PubMed/Checkpoint">000C21</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C21</idno><idno type="wicri:Area/Ncbi/Merge">004133</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.</title><author><name sortKey="Aye, Win Lei" sort="Aye, Win Lei" uniqKey="Aye W" first="Win Lei" last="Aye">Win Lei Aye</name><affiliation wicri:level="1"><nlm:affiliation>Master of Primary Health Care Management Program, ASEAN Institute for Health Development, Mahidol University, Nakhonpathom, Thailand. wlaye@iom.int.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Master of Primary Health Care Management Program, ASEAN Institute for Health Development, Mahidol University, Nakhonpathom</wicri:regionArea><wicri:noRegion>Nakhonpathom</wicri:noRegion></affiliation></author><author><name sortKey="Puckpinyo, Apa" sort="Puckpinyo, Apa" uniqKey="Puckpinyo A" first="Apa" last="Puckpinyo">Apa Puckpinyo</name><affiliation wicri:level="1"><nlm:affiliation>ASEAN Institute for Health Development, Mahidol University, Nakhonpathom, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>ASEAN Institute for Health Development, Mahidol University, Nakhonpathom</wicri:regionArea><wicri:noRegion>Nakhonpathom</wicri:noRegion></affiliation></author><author><name sortKey="Peltzer, Karl" sort="Peltzer, Karl" uniqKey="Peltzer K" first="Karl" last="Peltzer">Karl Peltzer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Research and Innovation, University of Limpopo, Sovenga, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Department of Research and Innovation, University of Limpopo, Sovenga</wicri:regionArea><wicri:noRegion>Sovenga</wicri:noRegion></affiliation></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-HIV Agents (administration & dosage)</term><term>Anti-HIV Agents (therapeutic use)</term><term>Cross-Sectional Studies</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>Humans</term><term>Male</term><term>Medication Adherence (statistics & numerical data)</term><term>Middle Aged</term><term>Myanmar</term><term>Prevalence</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents antiVIH (administration et posologie)</term><term>Agents antiVIH (usage thérapeutique)</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Infections à VIH (traitement médicamenteux)</term><term>Myanmar</term><term>Mâle</term><term>Observance du traitement médicamenteux ()</term><term>Prévalence</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Medication Adherence</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Myanmar</term><term>Prevalence</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Myanmar</term><term>Mâle</term><term>Observance du traitement médicamenteux</term><term>Prévalence</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The provision of Anti-Retroviral Therapy (ART) was started in Myanmar in 2005 in collaboration with the National AIDS Program and the private sector. Successful clinical management of HIV-infected patients is subject to optimal adherence. The aim of the study was to determine the prevalence of adherence to ART and identify factors associated with non-adherence to ART among HIV infected adults registered in a private sector setting in Mon State, Myanmar.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28476150</PMID><DateCreated><Year>2017</Year><Month>05</Month><Day>06</Day></DateCreated><DateCompleted><Year>2017</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.</ArticleTitle><Pagination><MedlinePgn>391</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-017-4309-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The provision of Anti-Retroviral Therapy (ART) was started in Myanmar in 2005 in collaboration with the National AIDS Program and the private sector. Successful clinical management of HIV-infected patients is subject to optimal adherence. The aim of the study was to determine the prevalence of adherence to ART and identify factors associated with non-adherence to ART among HIV infected adults registered in a private sector setting in Mon State, Myanmar.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional study was conducted with adults living with HIV receiving ART at an HIV outpatient clinic between April and May 2016. A total of three hundred People Living with HIV(PLHIV) were interviewed using a pretested and structured questionnaire. The 30 days Visual Analog Scale (VAS) adherence instrument was used to assess the level of adherence. Multivariable logistic regression analysis was used to determine factors associated with non-adherence to ART.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 300 patients (male 37.7% and female 62.3%, with a mean age of 41.3 years, standard deviation 8.7), 84% reported ≥95% adherence to ART in the past month. Among 16% of those reporting non-adherence, major reasons for skipping the medication were being busy (23%), being away from home (17.7%) and being forgetful (12.3%). In multivariable logistic rgeression, low behavioural skills on ART adherence (OR = 0.31, 95% CI: 0.10-0.94), tobacco use (OR = 3.22, 95% CI:1.28-8.12), having disclosed their HIV status (OR = 0.07, 95% CI: 0.01-0.69), having a partner who was not on ART (OR = 4.25, 95% CI: 1.70-10.64) and among men, having erectile dysfunction (OR = 15.14, 95% CI: 1.41-162.66) were significant associated with ART non-adherence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Non-adherence to ART was associated with individual moderating factors and behavioral skills. Priority measures such as addressing risk behaviour and behavioural change communication tailored to individual patients' lifestyles requires comprehensive interventions to improve adherence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aye</LastName><ForeName>Win Lei</ForeName><Initials>WL</Initials><Identifier Source="ORCID">http://orcid.org/0000-0002-5498-7061</Identifier><AffiliationInfo><Affiliation>Master of Primary Health Care Management Program, ASEAN Institute for Health Development, Mahidol University, Nakhonpathom, Thailand. wlaye@iom.int.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Organization for Migration, Kamayut Township, Yangon, Myanmar. wlaye@iom.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puckpinyo</LastName><ForeName>Apa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASEAN Institute for Health Development, Mahidol University, Nakhonpathom, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peltzer</LastName><ForeName>Karl</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Research and Innovation, University of Limpopo, Sovenga, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HIV/STI and TB Research Programme, Human Sciences Research Council, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S119-22</RefSource><PMID Version="1">17133194</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Intern Med. 2001 Sep;16(9):606-13</RefSource><PMID Version="1">11556941</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Patient Prefer Adherence. 2015 Oct 29;9:1531-7</RefSource><PMID Version="1">26604706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2015 Sep;142(3):301-10</RefSource><PMID Version="1">26458346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):574-80</RefSource><PMID Version="1">23011397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 1998 Sep 14;158(16):1789-95</RefSource><PMID Version="1">9738608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Health Serv Res. 2015 May 05;15:188</RefSource><PMID Version="1">25939593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Int Assoc Provid AIDS Care. 2014 May-Jun;13(3):242-9</RefSource><PMID Version="1">23761217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Osong Public Health Res Perspect. 2015 Jun;6(3):192-200</RefSource><PMID Version="1">26430616</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2011 Dec;134(6):954-9</RefSource><PMID Version="1">22310828</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Disord Drug Targets. 2012 Oct;12(5):346-56</RefSource><PMID Version="1">23017163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2000 Jun;12(3):255-66</RefSource><PMID Version="1">10928201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):187-90</RefSource><PMID Version="1">12045681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Infect Dis. 2013 Mar 27;13:154</RefSource><PMID Version="1">23537416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 17;9(9):e107543</RefSource><PMID Version="1">25229671</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 2001 Jan;21(1):41-51</RefSource><PMID Version="1">11223313</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2016;28 Suppl 1:68-75</RefSource><PMID Version="1">26886514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glob Health Action. 2013 Mar 15;6:19570</RefSource><PMID Version="1">23497956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):322-6</RefSource><PMID Version="1">12439208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Int Assoc Provid AIDS Care. 2015 Jul-Aug;14(4):335-42</RefSource><PMID Version="1">25979257</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2000 Jun;30 Suppl 2:S171-6</RefSource><PMID Version="1">10860902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Sep 30;9(9):e108615</RefSource><PMID Version="1">25268903</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2008 Apr;22(4):291-9</RefSource><PMID Version="1">18422461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2000 Jul 4;133(1):21-30</RefSource><PMID Version="1">10877736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Patient Prefer Adherence. 2015 Mar 05;9:373-80</RefSource><PMID Version="1">25784793</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e53-62</RefSource><PMID Version="1">22334069</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2009 Jan 15;48(2):248-56</RefSource><PMID Version="1">19072715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Impot Res. 1999 Dec;11(6):319-26</RefSource><PMID Version="1">10637462</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2014 Mar;28 Suppl 2:S187-204</RefSource><PMID Version="1">24849479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2005 Jun;9(2):135-43</RefSource><PMID Version="1">15933833</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Med Health Sci Res. 2015 Jul-Aug;5(4):279-83</RefSource><PMID Version="1">26229717</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Public Health. 2013 Jun 28;13:617</RefSource><PMID Version="1">23809431</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002052" MajorTopicYN="N">Myanmar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-retroviral therapy</Keyword><Keyword MajorTopicYN="N">HIV-infected adults</Keyword><Keyword MajorTopicYN="N">Myanmar</Keyword><Keyword MajorTopicYN="N">Non-adherence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>08</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>04</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28476150</ArticleId><ArticleId IdType="doi">10.1186/s12889-017-4309-5</ArticleId><ArticleId IdType="pii">10.1186/s12889-017-4309-5</ArticleId><ArticleId IdType="pmc">PMC5420085</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Afrique du Sud</li><li>Thaïlande</li></country></list><tree><country name="Thaïlande"><noRegion><name sortKey="Aye, Win Lei" sort="Aye, Win Lei" uniqKey="Aye W" first="Win Lei" last="Aye">Win Lei Aye</name></noRegion><name sortKey="Puckpinyo, Apa" sort="Puckpinyo, Apa" uniqKey="Puckpinyo A" first="Apa" last="Puckpinyo">Apa Puckpinyo</name></country><country name="Afrique du Sud"><noRegion><name sortKey="Peltzer, Karl" sort="Peltzer, Karl" uniqKey="Peltzer K" first="Karl" last="Peltzer">Karl Peltzer</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004133 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 004133 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28476150
|texte= Non-adherence to anti-retroviral therapy among HIV infected adults in Mon State of Myanmar.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28476150" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |